A retrospective cohort study found that adding 18F-sodium fluoride PET/CT to staging in newly diagnosed nasopharyngeal carcinoma reclassified tumor or metastasis categories in a minority of patients and also changed radiotherapy target volumes. The results suggest the imaging step can meaningfully alter treatment design for selected cases.